Centro de Novos Tratamentos Itajai

Itajaí, Santa Catarina 88301-220

0 studies enrolling now · 3 studies all time

What they study most

Cervical Cancer, Cutaneous Squamous Cell Carcinoma, Recurrent or Metastatic, Platinum-refractory Cervical Cancer, Squamous Cell Carcinoma (SCC)

Studies at this site

• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy — Completed
• Study of Cemiplimab in Adults With Cervical Cancer — Completed